Careers  |  Sign In  |  Register  |   Twitter

Latest in Business of Medicine

The state Department of Health of Massachusetts reported a 19% increase in Lyme disease occurrences since 2011 but until now insurance has not covered care for these patients for longer than 28 days, The Boston Globe reports. A new bill, sponsored by Representative Theodore Speliotis, is being pushed to...
"GlaxoSmithKline Plc (GSK)’s much-maligned diabetes drug Avandia will be released from restrictions preventing sales to certain patients after U.S. regulators determined new data show the medicine doesn’t raise heart risks," according to an article published by Bloomberg News. "The FDA restricted...
The New York Times reports on an FDA crackdown on a genetic test offered directly to consumers by Google-backed company 23andMe. The test, called the Personal Genome Service (P.G.S.), "analyzes the DNA in a saliva sample to tell consumers, among other things, whether they might be at a higher or lower risk...